A Novel Substituted Benzo[g]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent
Alicia Marco, Jana Kasparkova, Delia Bautista, Hana Kostrhunova, Natalia Cutillas, Lenka Markova, Vojtech Novohradsky, José Ruiz, Viktor Brabec · 2024
Read A Novel Substituted Benzo[g]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent by Alicia Marco, Jana Kasparkova, Delia Bautista, Hana Kostrhunova, Natalia Cutillas, Lenka Markova, Vojtech Novohradsky, José Ruiz, Viktor Brabec (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11647881.txt.
Description
Alicia Marco and co-authors built ruthenium compounds that attack colon cancer cells only when lit, in a 2024 study. Three metal complexes were made around a broad flat ligand. In cervical, skin, and colon cancer cells they stayed mild in the dark but turned strongly toxic under light, above all blue light. The best of them reached a hundredfold gap between dark and lit harm.
The lead compound settles in cell membranes. Light makes it spawn reactive oxygen that chews the membrane fats, tripping a death program in the cell. It even killed colon cancer stem cells, the hardy few blamed for relapse and spread. The authors claim a first for ruthenium in that role.
Catalog record
| CREATOR | Alicia Marco, Jana Kasparkova, Delia Bautista, Hana Kostrhunova, Natalia Cutillas, Lenka Markova, Vojtech Novohradsky, José Ruiz, Viktor Brabec |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |